1-37537781-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024700.4(SNIP1):āc.1158T>Gā(p.Asp386Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000139 in 1,614,014 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D386N) has been classified as Uncertain significance.
Frequency
Consequence
NM_024700.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SNIP1 | NM_024700.4 | c.1158T>G | p.Asp386Glu | missense_variant | 4/4 | ENST00000296215.8 | |
LOC105378649 | XR_947190.3 | n.621-908A>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SNIP1 | ENST00000296215.8 | c.1158T>G | p.Asp386Glu | missense_variant | 4/4 | 1 | NM_024700.4 | P1 | |
SNIP1 | ENST00000638725.1 | n.1670T>G | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152098Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000279 AC: 70AN: 251306Hom.: 1 AF XY: 0.000280 AC XY: 38AN XY: 135826
GnomAD4 exome AF: 0.000133 AC: 195AN: 1461798Hom.: 1 Cov.: 31 AF XY: 0.000129 AC XY: 94AN XY: 727196
GnomAD4 genome AF: 0.000197 AC: 30AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74454
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia | Jul 30, 2015 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 06, 2024 | The c.1158T>G (p.D386E) alteration is located in exon 4 (coding exon 4) of the SNIP1 gene. This alteration results from a T to G substitution at nucleotide position 1158, causing the aspartic acid (D) at amino acid position 386 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 386 of the SNIP1 protein (p.Asp386Glu). This variant is present in population databases (rs368368736, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with SNIP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 252743). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The glutamic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at